Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial ; volume:22 ; number:1 ; day:19 ; month:7 ; year:2024 ; pages:1-8 ; date:12.2024
Thrombosis journal ; 22, Heft 1 (19.7.2024), 1-8, 12.2024
- Urheber
-
Mansouri, Pejman
Jazi, Zahra Azamian
Mansouri, Mohammad Hadi
Dehghan, Hooman
Zavar, Reihaneh
Hashemi, Seyedeh Melika
Sattar, Fereshteh
Sadeghi, Masoumeh
Amirpour, Afshin
Abdar, Morteza
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-024-00632-5
- URN
-
urn:nbn:de:101:1-2410052129037.082455702856
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mansouri, Pejman
- Jazi, Zahra Azamian
- Mansouri, Mohammad Hadi
- Dehghan, Hooman
- Zavar, Reihaneh
- Hashemi, Seyedeh Melika
- Sattar, Fereshteh
- Sadeghi, Masoumeh
- Amirpour, Afshin
- Abdar, Morteza
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rivaroxaban versus warfarin for the management of left ventricle thrombus
The case of the disappearing left ventricular apical thrombus
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Left ventricular apical diseases
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
Right ventricular thrombus after penetrating cardiac injury
Rivaroxaban versus warfarin for the management of left ventricle thrombus
The case of the disappearing left ventricular apical thrombus
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Left ventricular apical diseases
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
Right ventricular thrombus after penetrating cardiac injury
Rivaroxaban versus warfarin for the management of left ventricle thrombus
The case of the disappearing left ventricular apical thrombus
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Left ventricular apical diseases
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke